TY - JOUR AU - Bruix, J TI - Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies JO - J Hepatol VL - 67 PY - 2017 DO - 10.1016/j.jhep.2017.06.026 L3 - PubMed-ID: 28687477 SP - 999 EP - 1008 N1 - et al. ER -